drugset / Trial / NCT02274311

Clomiphene Citrate for Treatment of Acromegaly

NCT02274311

Phase 2 Completed 16 enrolled Felipe Henning Gaia Duarte
NaSingle-groupOpen-labelTreatment

Summary

To assess the impact of clomiphene citrate on serum insulin like growth factor 1 and testosterone levels in male acromegalic patients not controlled by surgery, radiotherapy and/or medical treatments (somatostatin analogues, dopamine agonists and/or growth hormone receptor antagonist)

Timeline

Start
2011-01
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Clomiphene Other / unclassified 50 mg Oral

Indications